Back to Awarded Treatment Trials
Awarded Trial: 21T-002.b
Grant ID
21T-002.b
Illness
Schizophrenia
Primary Drug/Intervention
Luteolin
Primary Dosage
300 mg BID
Secondary Drug Intervention
N/A
Secondary Dosage
N/A
Other Drug/Intervention
N/A
Other Dosage
N/A
Status
Enrolling
Investigator
Stephen Marder
Sample Size
33
Duration of Study Period for Each Subject
12 weeks
Outcome Measurements
PANSS for global psychopathology and positive symptoms Brief Negative Symptom Scale for negative symptoms CGI severity of illness MATRICS Consensus Cognitive Battery (MCCB) to assess neuropsychological test performance. Global Measure of Oxidative Stress Inflammatory Measures Medical Assessments
Results
N/A
Publication
N/A
Link
N/A
PI Name
Stephen Marder
Degree
N/A
Center
Semel Institute NPI
Institution
The Regents of the University of California, Los Angeles
Address
760 Westwood Plaza
City or Town
Los Angeles
State or Province
CA
Zip or Postal Code
90024-1759
Country
USA
Email Address
marder@ucla.edu